Decline depth
-28.8%
From rolling 252-day high of $24.27, 55d ago.
Past the 20% Watch threshold.
-28.8%
from rolling 252-day high of $24.27 set 2026-05-07 · 55d ago
Current
$17.29
Decline depth
-28.8%
Decline σ
2.7σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$AVTX landed on the list 2026-03-14, down 22.7% from its 52-week high that day — now down -28.8%.
It has clawed back 13.6 percentage points off that level. It bottomed 38.5% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
AVTX qualifies for the Watch on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.7σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (5.36% per day).
The structural read
What price action says about AVTX.
AVTX qualifies for the Watch on decline depth — down -28.8% from its rolling 252-day high.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 1 (red).
52-week range
52W low $3.39
80.2% of range
52W high $20.72
Sector context · Healthcare
153 other Healthcare tickers are on Broken Stocks.
71
Red List
32
Amber
50
Watch
-34.6%
Median decline
Worst in sector: UPB (-78.4%). Least-bad: TMO (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to AVTX
Watch
NVO
Novo Nordisk A/S
WatchRecovering
DMAC
DiaMedica Therapeutics Inc.
Amber List
TARS
Tarsus Pharmaceuticals, Inc.
WatchRecovering
HCA
HCA Healthcare, Inc.
Amber ListRecovering
CRSP
CRISPR Therapeutics AG
Watch
COLL
Collegium Pharmaceutical, Inc.
Questions about AVTX
What people ask.
Why is AVTX on Broken Stocks?
AVTX qualifies for the Watch on decline depth. It is down -28.8% from its rolling 252-day high of $24.27, set on 2026-05-07 — 55d ago.
Is AVTX a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. AVTX is down -28.8% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is AVTX a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is AVTX trading inside its 52-week range?
At $17.29, AVTX sits 80.2% of the way from its 52-week low ($3.39) to its 52-week high ($20.72). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has AVTX been declining?
The current 28.8% decline accrued over 55d, which annualizes to roughly -191.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does AVTX compare to its sector?
There are 153 other Healthcare tickers on Broken Stocks: 71 Red, 32 Amber, 50 Watch, with 70 showing recovering structural signals. Median sector decline is -34.6% — AVTX's decline is shallower than the sector median.